Obinutuzumab for Systemic Lupus Erythematosus Pure Membranous Nephropathy: a Phase II Trial
Clinical trial NCT07721363 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07721363
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-02
- Primary completion
- 2029-09-02
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.